Neck News and Research

RSS

Overactive thyroid gland may increase risk of hospitalization for heart and blood-vessel disease

An overactive thyroid gland, or hyperthyroidism, may increase the risk of hospitalization for heart and blood-vessel disease even after surgery to remove the gland, according to a new study. The results will be presented Saturday at The Endocrine Society's 94th Annual Meeting in Houston.

25 Jun 2012

$Hip fracture type may determine regional anesthesia benefits$

Hip fracture type may determine regional anesthesia benefits

Use of regional anesthesia may reduce the risk for mortality and pulmonary complications among patients undergoing surgery for hip fracture, research shows.

22 Jun 2012

$Hip fracture type may determine regional anesthesia benefits$

Hip fracture type may determine regional anesthesia benefits

Use of regional anesthesia may reduce the risk for mortality and pulmonary complications among patients undergoing surgery for hip fracture, research shows.

21 Jun 2012

Even small-stage oral SCC metastases impact prognosis

The presence of even small tumor-cell deposits in the lymph nodes of patients with early oral and oropharyngeal squamous cell carcinoma reflects a potential for the primary tumor to metastasize, report researchers in Head and Neck.

21 Jun 2012

Viewpoints: Health law can be intensely personal; Insurers' promises miss the mark

Whenever I read or hear objections to "Obamacare," I think about my friend's son. The son had cancer when he was a teenager. Thankfully, his dad had health insurance -- through his job. A job that he lost. He has a new job now, but like so many new jobs, it doesn't pay as much -- and it doesn't come with benefits. Fortunately, his son seems to have beaten the cancer. And the family now has health insurance from the mom's job. So the son, thanks to "Obamacare," can be insured through his parents.

21 Jun 2012

Agility MLC's new design provides better dose sculpting capabilities

Requiring only a quick upgrade to their existing Elekta Synergy linear accelerator, physicians at SALK and Paracelsus Medical University began using the new Agility 160-leaf multileaf collimator (MLC), treating 33 patients on its first day. In its first month of Agility use, the center now treats 50 patients per day, comprising about 700 individual treatment sessions that have benefited from this breakthrough in cancer care.

From Elekta 18 Jun 2012

Is curry good for you?

There have been several news stories over the years reporting that curry may be good for us. Most of them refer to a chemical in curry, known as curcumin.

18 Jun 2012

Transplantation of tissue-engineered vein is a success and offers hope for patients who lack suitable veins for dialysis or bypass surgery

The first biologically tissue-engineered vein grown from a patient’s own stem cells has been successfully transplanted into a 10-year-old girl with portal vein obstruction, dramatically enhancing her quality of life.

15 Jun 2012

Hysterectomy may increase risk of cardiovascular disease in postmenopausal women

Estrogen-deficient, postmenopausal women who have had their uterus removed appear to have stiffer arteries compared to similar women who have not had a hysterectomy, according to new research from the University of Colorado School of Medicine.

14 Jun 2012

Liposuction effective in treating submental lymphedema in patients with head and neck cancer

Liposuction is a novel and minimally invasive procedure for treating persistent submental lymphedema in patients with previous head and neck cancer, according to an article published in the June 2012 issue of Otolaryngology-Head and Neck Surgery.

13 Jun 2012

New combination therapy can help improve cure rates for neuroblastoma

An experimental treatment that combines intense chemotherapy with a radioactive isotope linked to synthesized neurotransmitter is being tested in newly diagnosed cases of high-risk neuroblastoma - a deadly, hard-to-cure childhood cancer.

13 Jun 2012

Presidential campaigns jockey for support from seniors, Hispanic voters

Press reports detail how both the Romney and Obama campaigns are taking steps to attract these voting blocs.

12 Jun 2012

Ethnic minority women ill-informed about heart disease

Black and Hispanic women are less likely than White women to be aware of heart disease risk and the symptoms of a heart attack, researchers say.

11 Jun 2012

UF Proton Therapy Institute successfully treats first eye cancer patient

The fixed beam room, or eyeline, at the University of Florida Proton Therapy Institute is up and running and radiation oncologist Robert Malyapa, M.D., Ph.D. completed treating the facility's first eye cancer patient this week.

10 Jun 2012

New synthetic vaccine effective in killing HPV-derived cancer

Researchers at Moffitt Cancer Center have developed and tested in mice a synthetic vaccine and found it effective in killing human papillomavirus-derived cancer, a virus linked to cervical cancers among others.

10 Jun 2012

Adolescent mental disorders have repercussions for addiction

Adolescents with mental health disorders are significantly more likely to become addicted to prescription opioid pain relievers than those without mental disorders, experts say.

8 Jun 2012

Vitamin A supplements may reduce skin cancer risk

Taking vitamin A supplements reduces the risk for developing a deadly form of skin cancer called melanoma, say US researchers.

8 Jun 2012

Experts debate whether spinal manipulation for neck pain should be abandoned

The effectiveness of spinal manipulation divides medical opinion. On bmj.com today, experts debate whether spinal manipulation for neck pain should be abandoned.

8 Jun 2012

Aldosteronism linked to poor bone health

Primary aldosteronism is associated with low bone mass, increased prevalence of osteoporosis, and vertebral fractures, Italian research shows.

7 Jun 2012

Neurotech’s ADNS-300 system obtains European CE Mark approval

Neurotech s.a., a Belgium based developer and manufacturer of neurostimulation devices, announces that it has obtained the European CE Mark for its ADNS-300 system dedicated to the treatment of refractory epilepsy.

7 Jun 2012